Carson Harms

Carson Harms has a diverse work experience in the scientific and research field. Carson started their career at Santa Clara University as a Student Researcher where they studied transcription factors controlling cell fate in a model organism. Carson gained relevant skills in organism culture, DNA vector assembly, and mRNA production.

After their undergraduate studies, Carson joined the University of Washington as a Molecular Engineering Research Associate, where they worked from September 2014 to June 2016.

In 2016, Carson joined Fred Hutch as a Research Technician, where they worked until October 2019.

Carson's most recent role is at Lyell Immunopharma, where they held two positions. Carson started as a Sr. Research Associate, Process Development in October 2019 and later transitioned to the role of Scientist, Process Development in April 2021.

Throughout their work experience, Carson has developed a strong foundation in research and scientific methodologies, gaining expertise in process development and molecular engineering.

Carson Harms has a Bachelor of Science degree in Bioengineering from Santa Clara University. Additionally, they have pursued further education and obtained a Master's Degree in Molecular Engineering from the University of Washington. The specific start and end years for both degrees were not provided.